Praxis Precision Medicines, Inc. (PRAX) Financial Statements (2026 and earlier)

Company Profile

Business Address 99 HIGH STREET, 30TH FLOOR
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:926,100469,50081,300100,489275,900296,608
Cash and cash equivalent357,329215,37281,30061,615138,704296,608
Short-term investments242,002177,195 38,874105,678 
Other undisclosed cash, cash equivalents, and short-term investments326,76976,933  31,518 
Other undisclosed current assets(315,189)(65,128)3,58010,35111,5095,718
Total current assets:610,911404,37284,880110,840287,409302,326
Noncurrent Assets
Operating lease, right-of-use asset921,1312,0642,9013,653754
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1472305889711,21382
Long-term investments and receivables326,75776,961    
Long-term investments326,75776,961    
Other noncurrent assets  41641641647215
Total noncurrent assets:326,99678,7383,0684,2885,338851
TOTAL ASSETS:937,907483,11087,948115,128292,747303,177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59,66136,29113,23130,52237,62414,957
Accounts payable24,62812,5285,81514,67210,7804,088
Accrued liabilities35,03323,7637,41615,85026,84410,869
Deferred revenue   1,3922,818  
Other undisclosed current liabilities1101,2591,1261,005810763
Total current liabilities:59,77137,55015,74934,34538,43415,720
Noncurrent Liabilities
Long-term debt and lease obligation:     3,501 
Liabilities, other than long-term debt  1102,5304,677  
Deferred revenue   1,1612,182  
Operating lease, liability  1101,3692,4953,501 
Other undisclosed noncurrent liabilities     (3,501) 
Total noncurrent liabilities:  1102,5304,6773,501 
Total liabilities:59,77137,66018,27939,02241,93515,720
Equity
Equity, attributable to parent878,136445,45069,66976,106250,812287,457
Common stock151413554
Additional paid in capital2,017,5661,281,522723,577606,918567,598437,007
Accumulated other comprehensive income (loss)563654 (173)(176) 
Accumulated deficit(1,140,008)(836,740)(653,921)(530,644)(316,615)(149,554)
Total equity:878,136445,45069,66976,106250,812287,457
TOTAL LIABILITIES AND EQUITY:937,907483,11087,948115,128292,747303,177

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues  8,5532,447   
Gross profit:  8,5532,447   
Operating expenses(326,198)(208,718)(128,820)(214,986)(167,332)(61,968)
Operating loss:(326,198)(200,165)(126,373)(214,986)(167,332)(61,968)
Nonoperating income22,93017,3463,096957271140
Other nonoperating income22,93017,3463,096   
Loss from continuing operations before equity method investments, income taxes:(303,268)(182,819)(123,277)(214,029)(167,061)(61,828)
Other undisclosed income from continuing operations before income taxes471     
Loss from continuing operations before income taxes:(302,797)(182,819)(123,277)(214,029)(167,061)(61,828)
Income tax expense (benefit) (471)    8
Other undisclosed loss from continuing operations      
Loss from continuing operations:(303,268)(182,819)(123,277)(214,029)(167,061)(61,820)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(167,061)(61,820)
Net loss attributable to parent:(303,268)(182,819)(123,277)(214,029)(167,061)(61,820)
Other undisclosed net loss available to common stockholders, basic      (8,503)
Net loss available to common stockholders, diluted:(303,268)(182,819)(123,277)(214,029)(167,061)(70,323)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(303,268)(182,819)(123,277)(214,029)(167,061)(61,820)
Comprehensive loss:(303,268)(182,819)(123,277)(214,029)(167,061)(61,820)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(91)6541733(176) 
Comprehensive loss, net of tax, attributable to parent:(303,359)(182,165)(123,104)(214,026)(167,237)(61,820)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: